Latest Commercialization News

Viva Energy's half-year results reveal a resilient Commercial segment offsetting pressures in Refining and Retail, as the company advances its retail transformation and cost synergy targets.

Viva Energy’s half-year results reveal strong momentum in its Convenience & Mobility segment and ongoing refinery enhancements, despite a challenging start to 2025. The Group’s strategic acquisitions and store expansions underpin a cautiously optimistic outlook.

Nanosonics delivered a robust FY25 with 17% revenue growth and a 72% jump in profit before tax, propelled by next-gen trophon devices and advancing CORIS commercialisation.

Viva Energy reported a statutory half-year loss of $195.4 million driven by significant retail site impairments and weak refining margins, yet underlying profit on a replacement cost basis remained positive at $62.6 million. The company declared a fully franked interim dividend of 2.83 cents per share, signaling confidence despite operational headwinds.

Aurelia Metals has reported a robust turnaround in FY25 with a 69% jump in EBITDA and a return to profitability, driven by operational gains at Peak and Federation. The company is advancing key growth projects targeting 40kt copper equivalent production by FY28.

Aurelia Metals Limited has reported a strong turnaround with a $48.9 million net profit for FY25, driven by operational progress at its Federation Mine and the approval of the Great Cobar Project. The company’s strategic focus on base metals growth and sustainability underpins its improved financial and safety performance.

Premier1 Lithium has announced its first inferred mineral resource at the Wadgingarra gold project, marking a significant step towards commercial gold production with promising expansion potential.

Sparc Technologies reveals up to 60% corrosion reduction in graphene-enhanced water-based epoxy coatings, reinforcing its leadership in sustainable protective coatings innovation.

Fortescue Metals Group reported a robust FY25 with record iron ore shipments and strong profits, while advancing its green metal and decarbonisation initiatives. The company also provided solid FY26 guidance amid ongoing exploration and capital discipline.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Firebrick Pharma has closed a $1.4 million placement to fund expansion of its Nasodine nasal spray in key international markets and advance new product development.